Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Peginterferon alfa-2a |
Pegasys |
Image:PEGASYS.png PEGASYS Systematic (IUPAC) name ? Identifiers CAS number 215647-85-1 ATC code L03AB11 PubChem ? Chemical data Formula ? Mol. weight ? Pharmacokinetic data Bioavailability ? Metabolism ? Half life ? Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status ? Routes ? Pegylated interferon alfa 2a (40KD) (commercial name PEGASYS) is an antiviral drug discovered at t ...
Wikipedia - [full article]
Resources
- Pegasys (Drug Digest)
- Peginterferon alfa-2a (Drug Digest)
Peginterferon alfa-2a News Headlines
- Copegus Approved In Japan As Combination Therapy With Pegasys For Patients With Chronic Hepatitis C
MedicalNewsToday - Mon, 29 Jan 2007 08:00 EST
- Manhattan Pharmaceuticals Completes Enrollment In Phase 2a Study Of Oral Oleoyl-estrone For Obesity
MedicalNewsToday - Thu, 22 Feb 2007 08:00 EST
- Biolex Therapeutics Announces Initiation Of Locteron(TM) Phase 2 Clinical Study In Chronic Hepatitis C
MedicalNewsToday - Wed, 31 Jan 2007 08:00 EST
- Lilly Plans New Clinical Trial Of Xigris(R)
MedicalNewsToday - Tue, 27 Feb 2007 08:00 EST
- Human Genome Sciences Initiates Phase 3 Clinical Trial Of Albuferon(R) With Ribavirin In Patients With Chronic Hepatitis C Genotypes 2 And 3
MedicalNewsToday - Wed, 28 Feb 2007 08:00 EST
- BioMarin Announces Results From Phase 2 Clinical Study Of 6R-BH4 In Poorly Controlled Hypertension
MedicalNewsToday - Wed, 21 Feb 2007 08:00 EST
- Dainippon Sumitomo Pharma Announces Launch Of "Replagal(R) 3.5 Mg" For Anderson-Fabry Disease
MedicalNewsToday - Sun, 18 Feb 2007 08:00 EST
- Pharmos Announces Clinical Data From Phase 2a Trial Of Cannabinor For Capsaicin-induced Pain
MedicalNewsToday - Sat, 20 Jan 2007 08:00 EST
- Viragen Reports OVA(TM) System Milestone: Interferon Alpha Expressed In Eggs
MedicalNewsToday - Thu, 25 Jan 2007 08:00 EST
- Aerovance Announces Positive Top-Line Results From Phase 2a Trial Of Inhaled AEROVANT(TM) In Asthma Patients
MedicalNewsToday - Fri, 05 Jan 2007 08:00 EST
- Metabolex Begins Phase 2a, Proof-of-Concept Study For MBX-2044 Diabetes Drug
MedicalNewsToday - Thu, 21 Dec 2006 08:00 EST
- Dynavax Reports Positive Phase 2a NHL Data At ASH Meeting
MedicalNewsToday - Mon, 11 Dec 2006 08:00 EST
- Amgen Responds To Reports About Use And Safety Of EPOGEN And Aranesp In CKD Anemia Therapy
MedicalNewsToday - Mon, 11 Dec 2006 08:00 EST
- Majority Of Cancer-Related Anemia Patients Treated With PROCRIT(R) (Epoetin Alfa) Once Every Three Weeks Achieved Target Hemoglobin
MedicalNewsToday - Sat, 09 Dec 2006 08:00 EST
- Assisted Living Compensation Report Released - First Ever Details On Salaries, From Front-line To Corner Office
MedicalNewsToday - Fri, 01 Dec 2006 08:00 EST
- Memory Pharmaceuticals Earns Milestone Payment For Phase 2a Trial Of MEM 1003 In Bipolar Disorder
MedicalNewsToday - Tue, 21 Nov 2006 08:00 EST
- New Phase 2 Data Show Promise Of Aranesp(R) Treatment For Anemia Of Cancer
MedicalNewsToday - Mon, 11 Dec 2006 08:00 EST
- Majority Of Anemic Chronic Kidney Disease Pre-Dialysis Patients Achieved Target Hemoglobin Range With PROCRIT® (Epoetin Alfa)
MedicalNewsToday - Thu, 23 Nov 2006 08:00 EST
- Final Phase 2 Data Continue To Show Promising Results After One Year Of Aranesp(R) Treatment For Anemia In Patients With Myelodysplastic Syndromes
MedicalNewsToday - Mon, 11 Dec 2006 08:00 EST
- No antibiotics for ear infections
MSNBC - Sun, 10 Dec 2006 07:40 EST
- Majority Of Anemic Chronic Kidney Disease Pre-Dialysis Patients Achieved Target Hemoglobin Range With PROCRIT(R) (Epoetin Alfa) Therapy
MedicalNewsToday - Mon, 20 Nov 2006 08:00 EST
- Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites To US
MedicalNewsToday - Thu, 09 Nov 2006 08:00 EST
- Memory Pharmaceuticals Completes Enrollment For MEM 1003 Bipolar Trial
MedicalNewsToday - Tue, 28 Nov 2006 08:00 EST
- District Court Judge Denies Preliminary Injunction In Ortho V. Amgen Suit
MedicalNewsToday - Thu, 23 Nov 2006 08:00 EST
- African Americans Have Lower Response Rate To Standard Therapy For Hepatitis C
MedicalNewsToday - Sat, 19 Aug 2006 10:00 EST
- Memory Pharmaceuticals Provides Update On Phase 2a Trial Of MEM 3454 In Alzheimer's Disease
MedicalNewsToday - Tue, 17 Oct 2006 07:00 EST
- Mom gets 2 1/2 years in pierced navel case
MSNBC - Thu, 26 Oct 2006 10:11 EST
- Amgen Receives Complete Response Letter For Extended Dosing Of Aranesp(R) For Patients With Chronic Kidney Disease And Anemia
MedicalNewsToday - Sun, 15 Oct 2006 07:00 EST
- Memory Pharmaceuticals Initiates Phase 2a Trial Of MEM 1003 In Bipolar Disorder
MedicalNewsToday - Wed, 06 Sep 2006 07:00 EST
- Study Shows Patient Preference For Gonal-f(R) RFF Pen To Treat Infertility
MedicalNewsToday - Tue, 26 Sep 2006 07:00 EST
- New Treatment A Success For Anaemia Associated With Chronic Kidney Disease
MedicalNewsToday - Sat, 16 Sep 2006 07:00 EST
- A Well-Rounded View Of The Fly Synapse
MedicalNewsToday - Sat, 09 Sep 2006 02:00 EST
- Amgen Launches Aranesp Prefilled Sureclick™ Autoinjector For Treatment Of Anemia
MedicalNewsToday - Sun, 10 Sep 2006 11:00 EST
- New Autoinjector Offers Secure And Simple Way To Administer Anemia Treatment Associated With Chemotherapy And Chronic Kidney Disease
MedicalNewsToday - Sun, 10 Sep 2006 07:00 EST
- Pharmos Commences Dosing In Second Phase 2a Study Of Cannabinor In Experimentally Induced Pain
MedicalNewsToday - Fri, 11 Aug 2006 06:00 EST
- Favourable Phase 2a Pharmacokinetic And Safety Data For Glypromate(R) Confirmed
MedicalNewsToday - Wed, 23 Aug 2006 07:00 EST
- Advate's Safety Profile Confirmed For Haemophilia Therapy
MedicalNewsToday - Mon, 21 Aug 2006 07:00 EST
- Pharmos Commences Patient Dosing In Phase 2a Cannabinor Nociceptive Pain Study
MedicalNewsToday - Fri, 30 Jun 2006 06:00 EST
- Pharmos Phase 2a Cannabinor Study To Evaluate Analgesic Activity And Safety In Acute Pain Approved By UK Regulatory Authorities
MedicalNewsToday - Wed, 21 Jun 2006 06:00 EST
- Aranesp May Lower Hospitalization Risk And All-Cause Mortality In Heart Failure Patients With Anemia, Based On A Prespecified Pooled Analysis
MedicalNewsToday - Mon, 26 Jun 2006 06:00 EST
- Anacor Announces Positive Results From Phase 2 Trial Of Novel Anti-Inflammatory Agent For The Treatment Of Atopic Dermatitis
MedicalNewsToday - Fri, 16 Jun 2006 06:00 EST
- Study Explores Use Of PROCRIT(R) (Epoetin Alfa) Once Every Two Weeks As Initiation Treatment For Chemotherapy-Related Anemia
MedicalNewsToday - Sun, 04 Jun 2006 06:00 EST
- Study Of Aranesp(R) Dosed Every Two Weeks Versus Epoetin Alfa Dosed Weekly
MedicalNewsToday - Mon, 22 May 2006 06:00 EST
- ASCO 2006 - Plenary Session: Renal Cell Cancer
MedicalNewsToday - Sun, 11 Jun 2006 11:00 EST
- Update On Oral HCV Protease Inhibitor SCH 503034 Clinical Development Program For Hepatitis C
MedicalNewsToday - Wed, 26 Apr 2006 06:00 EST
- European Medicines Agency Adopts First Positive Opinion For A Medicinal Product Derived From Transgenic Biotechnology
MedicalNewsToday - Mon, 05 Jun 2006 02:00 EST
- Hepatitis C Patients Benefit From Combination Of VX-950 And Pegylated Interferon
MedicalNewsToday - Tue, 02 May 2006 06:00 EST
- Positive Preliminary Results From A Phase 2a Clinical Trial Of XP19986 As A Treatment For Gastroesophageal Reflux Disease
MedicalNewsToday - Tue, 23 May 2006 06:00 EST
- XenoPort Announces Presentation Of XP13512 Data At The American Pain Society Meeting
MedicalNewsToday - Fri, 05 May 2006 06:00 EST
- Gilead Sciences Welcomes Guidance From Nice On Treatment Of Chronic Hepatitis B
MedicalNewsToday - Thu, 23 Feb 2006 12:00 EST
- FDA Approves First Treatment For Pompe Disease
MedicalNewsToday - Mon, 01 May 2006 06:00 EST
- Pompe Disease Drug Myozyme Gets FDA Approval
MedicalNewsToday - Sat, 29 Apr 2006 12:00 EST
- People With Chronic Hepatitis B To Benefit From Guidance On New Drugs And Treatments, UK
MedicalNewsToday - Wed, 22 Feb 2006 01:00 EST
- Kaiser Daily Health Policy Report Highlights Recent Developments In Medicare
MedicalNewsToday - Thu, 06 Apr 2006 07:00 EST
- FDA Approves Extended Dosing Of Aranesp
MedicalNewsToday - Thu, 30 Mar 2006 08:00 EST
- Amgen''s Phase 3 RED-HF(TM) Trial Will Evaluate The Clinical Effect Of Treating Anemia In Patients With Symptomatic Heart Failure
MedicalNewsToday - Sun, 19 Mar 2006 11:00 EST
- Crohn''s Disease - NPS To Advance Clinical Development Of Teduglutide As Treatment
MedicalNewsToday - Tue, 28 Feb 2006 06:00 EST
- Some Highlights From The February 15 JNCI
MedicalNewsToday - Sun, 19 Feb 2006 02:00 EST
- Some Highlights From The February 15 JNCI
MedicalNewsToday - Sun, 19 Feb 2006 02:00 EST
- Schering-Plough Initiates PEG-INTRON(R) Maintenance Study In Patients Coinfected With Hepatitis C And HIV
MedicalNewsToday - Sun, 15 Jan 2006 11:00 EST
- Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved In Japan
MedicalNewsToday - Tue, 27 Dec 2005 11:00 EST
- Head-To-Head Study Of Treatments For Chemotherapy-Related Anemia Published In The Oncologist
MedicalNewsToday - Fri, 23 Sep 2005 06:00 EST
- Phase 3 Trial Starts to Evaluate the Impact of Treating Anemia with Darbepoetin Alfa in Patients with Heart Failure
MedicalNewsToday - Tue, 06 Sep 2005 12:00 EST
- Procrit® (Epoetin Alfa) Maintenance Treatment For Patients With Anemia From Chronic Kidney Disease
MedicalNewsToday - Mon, 15 Aug 2005 09:00 EST
- HIV - Phase 1/2a Study Results Indicate Maraviroc Well-Tolerated in Doses up to 300 mg Twice-Daily
MedicalNewsToday - Sun, 31 Jul 2005 01:00 EST
- Treating children with chronic hepatitis C - PegInterferon-alfa-2b with ribavirin shows promise
MedicalNewsToday - Mon, 02 May 2005 06:00 EST
- Major Response with Aranesp(R) in Anemic Patients with Myelodysplastic Syndromes (MDS)
MedicalNewsToday - Sun, 10 Jul 2005 06:00 EST
- Major response with Aranesp(R) in anemic patients with MDS
MedicalNewsToday - Thu, 07 Jul 2005 04:00 EST
- PEGASYS Plus Ribavirin COPEGUS, Combination Therapy for Hepatitis C, Trial Results
MedicalNewsToday - Sat, 25 Jun 2005 06:00 EST
- NeoRecormon offers patients maximum anaemia control with minimum injection discomfort compared to Aranesp
MedicalNewsToday - Fri, 03 Jun 2005 05:00 EST
- Low-Fat Recipes
Washington Post - Tue, 24 May 2005 12:42 EST
- Chemotherapy-Induced Anemia - Amgen Submits Supplemental Biologics License Application for Aranesp Extended Dosing
MedicalNewsToday - Mon, 09 May 2005 04:00 EST
email this page
print this page
bookmark this page
feedback on this page
